Clinical Results and RSA Migration Analysis of the GLOBAL ICON - Stemless Anatomic Shoulder

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-80
SponsorHannover Medical School

About this trial

The primary goal of the clinical trial is to determine that the GLOBAL ICON implant system from DePuy does not exhibit worse shoulder function after 2 years than the SIMPLICITY from Wright Medical. The primary endpoint is the Constant-Murley Shoulder Score (CMSS) of the implant after 2 years, the non-inferiority of which is to be demonstrated in comparison with an already established prosthetic system (SIMPLICITY, Wright Medical).

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Trial participants need primary total shoulder replacement due to primary osteoarthritis or post-traumatic osteoarthritis

Trial participants are willing to take part in the clinical trial and intend to be available for the planned follow-up examinations.

Male, female and various subjects with age on the day of surgery from 18 to 80 years inclusive.

Subjects agree not to participate in any other clinical trial for at least 2 years (+ 3 weeks) using the index procedure. This includes clinical trials of medication, invasive procedures and medical devices. Questionnaire-based studies or other studies that are non-invasive and do not involve drug use are allowed.

Disqualifiers

Previous operation on the rotator cuff of the affected shoulder

Dysfunctional rotator cuff

Infection of the affected shoulder joint or systemic infection

Pregnant or breastfeeding women and those who are planning to become pregnant for up to 2 years (+3 weeks) using the index procedure

Trial design

Design model

Parallel

Treatments tested in this trial

  • Total joint arthroplasty of the glenohumeral joint

    Device

    The arthroplasty of the glenohumeral joint will be performed as an anatomical reconstruction after primary or post-traumatic osteoarthritis.

Treatment groups

60 Participants
are divided into 2 treatment groups
Group A: Shoulder prosthesis system GLOBAL ICON from DePuyExperimental treatment 1 intervention
Group B: SIMPLICITY shoulder prosthesis system from Wright MedicalActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Constant-Murley Score (CMS)

The CMS covers different aspects of shoulder pathology: pain, activities of daily living, range of motion and strength. The possible maximum total score is 100 points (best function). Pain and activities of daily living are answered by the patient; range of motion and strength are answered by the orthopaedic surgeon.

Time frame
3 months postoperative
2

Constant-Murley Score (CMS)

The CMS covers different aspects of shoulder pathology: pain, activities of daily living, range of motion and strength. The possible maximum total score is 100 points (best function). Pain and activities of daily living are answered by the patient; range of motion and strength are answered by the orthopaedic surgeon.

Time frame
12 months postoperative
3

Constant-Murley Score (CMS)

The CMS covers different aspects of shoulder pathology: pain, activities of daily living, range of motion and strength. The possible maximum total score is 100 points (best function). Pain and activities of daily living are answered by the patient; range of motion and strength are answered by the orthopaedic surgeon.

Time frame
24 months postoperative

Secondary outcomes

1

Oxford Shoulder Score (OSS)

The Oxford Shoulder Score (OSS) is a 12-item patient-reported questionnaire specifically designed for assessing outcomes of shoulder surgery e.g. for assessing the impact on patients' quality of life of degenerative conditions such as arthritis and rotator cuff problems. Scores from each question are added so the overall score ranges from 12 to 60 with 12 being the best out-come.

Time frame
3 months postoperative
2

Oxford Shoulder Score (OSS)

The Oxford Shoulder Score (OSS) is a 12-item patient-reported questionnaire specifically designed for assessing outcomes of shoulder surgery e.g. for assessing the impact on patients' quality of life of degenerative conditions such as arthritis and rotator cuff problems. Scores from each question are added so the overall score ranges from 12 to 60 with 12 being the best out-come.

Time frame
12 months postoperative
3

Oxford Shoulder Score (OSS)

The Oxford Shoulder Score (OSS) is a 12-item patient-reported questionnaire specifically designed for assessing outcomes of shoulder surgery e.g. for assessing the impact on patients' quality of life of degenerative conditions such as arthritis and rotator cuff problems. Scores from each question are added so the overall score ranges from 12 to 60 with 12 being the best out-come.

Time frame
24 months postoperative
4

Short Form Health 36 (SF-36)

The Short Form (36) Health Survey is a 36-item, patient-reported survey of patient health consisting of eight scaled scores. Each scale is directly transformed into a 0-100 scale on the assumption that each question carries equal weight. The higher the score the less disability i.e., a score of zero is equivalent to maximum disability and a score of 100 is equivalent to no disability.

Time frame
3 months postoperative

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.